个人化细胞治疗市场按细胞类型、治疗领域、最终用户和地区划分

2025 年全球个人化细胞治疗市场规模估计为 175.9 亿美元，预计到 2032 年将达到 820.8 亿美元，2025 年至 2032 年的复合年增长率为 24.6%。

数字。 2025 年个人化细胞治疗市场占有率（按地区划分）

全球个人化细胞治疗市场的成长是由主要企业加大研发投入来开发先进的细胞疗法来治疗各种慢性和危及生命的疾病所推动的。个人化细胞疗法涉及从患者自身分离和操纵细胞以产生治疗效果。这一新领域可望开发出治疗癌症、神经系统疾病、心血管疾病等的治疗方法。基因组学、细胞生物学和工程技术的进步正在帮助科学家更好地了解细胞在健康和疾病状态下的功能。随着越来越多的细胞治疗产品获得监管部门核准并在临床中采用，市场可能会成长。

市场动态

全球个人化细胞治疗市场的成长受到多种因素的推动，例如癌症和其他无法治癒的疾病盛行率上升、老龄化人口增加且易患慢性病、再生医学的应用日益广泛、细胞治疗的应用不断扩大、生物技术的进步以及对基于细胞的研究的大量投资。然而，高昂的治疗成本、较长的开发週期以及临床试验的监管障碍可能会阻碍市场成长。持续研究 iPSC（诱导性多功能干细胞）技术、采用 CAR-T 细胞疗法、同种异体细胞疗法的研究和开发以及积累细胞疗法疗效的证据可以为相关人员提供有利可图的机会。

研究的主要特点

• 本报告对全球个人化细胞治疗市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球个人化细胞治疗市场主要企业根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行分析。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球个人化细胞疗法市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过全球个人化细胞治疗市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章 全球个人化细胞治疗市场-冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球个人化细胞治疗市场（按细胞类型划分）（十亿美元）

• 介绍
• 淋巴球
• 间质干细胞
• 造血干细胞
• 其他的

6. 2020 年至 2032 年按治疗领域分類的全球个人化细胞治疗市场（十亿美元）

• 介绍
• 心血管疾病
• 神经系统疾病
• 发炎性疾病
• 糖尿病
• 癌症

7. 2020 年至 2032 年全球个人化细胞治疗市场（按最终用户划分）（十亿美元）

• 介绍
• 医院
• 居家医疗
• 专科门诊
• 其他的

8. 2020 年至 2032 年全球个人化细胞治疗市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara BIoTherapeutics, Inc.
  • Holostem Terapie Avanzate Srl
• 兴衰
• 一致的机会地图

第十章参考文献与调查方法

• 参考
• 调查方法

Global Personalized Cell Therapy Market is estimated to be valued at USD 17.59 Bn in 2025 and is expected to reach USD 82.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 24.6% from 2025 to 2032.

Figure. Personalized Cell Therapy Market Share (%), By Region 2025

Global personalized cell therapy market growth is driven by increasing R&D investments by key players in developing advanced cell therapies for treating various chronic and life-threatening diseases. Personalized cell therapy involves isolation and manipulation of cells from patient's own body to produce therapeutic effects. This emerging field holds promise for developing curative treatments for cancer, neurological disorders, cardiovascular diseases and others. With advancements in genomics, cell biology and engineering technologies, scientists are gaining deeper understanding of how cells function in healthy and diseased conditions, thus, allowing them to exploit cells' therapeutic potential in a personalized way. The market can witness growth as more cell therapy products receive regulatory approvals and get adopted in clinical practice.

Market Dynamics:

Global personalized cell therapy market growth is driven by several factors such as rising prevalence of cancer and other incurable diseases, growing geriatric population susceptible to chronic illnesses, increasing adoption of regenerative medicines, expanding applications of cell therapies, advances in biotechnology, and heavy investments in cell-based research. However, high treatment costs, long development cycles, and regulatory hurdles surrounding clinical trials can hamper the market growth. Ongoing research on iPSC (induced pluripotent stem cells) technology, adoption of CAR T-cell therapies, development of allogenic cell therapies, growing body of evidence on effectiveness of cell therapies can offer lucrative opportunities for stakeholders.

Key Features of the Study:

• This report provides in-depth analysis of the global personalized cell therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global personalized cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Juno Therapeutics, Cellectis, Bellicum Pharmaceuticals, Vericel, Pharmicell, Pluristem Therapeutics, BioLineRx, Mesoblast.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global personalized cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized cell therapy market.

Detailed Segmentation-

• By Cell Type
  • Lymphocytes
  • Mesenchymal Stem Cell
  • Hematopoietic Stem Cell
  • Others
• By Therapeutic Area
  • Cardiovascular Diseases
  • Neurological Disorders
  • Inflammatory Diseases
  • Diabetes
• By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Thermo Fisher Scientific, Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Type
  • Market Snapshot, By Therapeutic Area
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Personalized Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Personalized Cell Therapy Market, By Cell Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Lymphocytes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mesenchymal Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematopoietic Stem Cell
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Personalized Cell Therapy Market, By Therapeutic Area, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Personalized Cell Therapy Market, By End Users, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Personalized Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Gilead Sciences, Inc.
  • Company Highlights
  • Therapeutic Area Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Amgen Inc.
  • Bluebird Bio, Inc.
  • Personalis, Inc.
  • Adaptimmune Therapeutics PLC
  • BioNTech SE
  • Sangamo Therapeutics, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • CRISPR Therapeutics AG
  • Caribou Biosciences, Inc.
  • Mustang Bio, Inc.
  • Fate Therapeutics, Inc.
  • Atara Biotherapeutics, Inc.
  • Holostem Terapie Avanzate S.r.l
• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"